What wont get its own plenary sessionbut will be discussed in hallways, exhibit halls, and dinners across the cityis the rapidly evolving role of compounding in dermatology practice
Identification of potential biomarkers for predicting acute dermal irritation by proteomic analysis
Our most popular weight loss treatment is GLP-1 medication, however we offer a variety of alternative treatments, including Peptide Therapy
The future of obesity pharmacotherapy appears to be trending toward multi-receptor approaches however, for patients beginning their weight loss journey today, semaglutide remains the most accessible, thoroughly studied, and clinically validated option
Risks and Unknowns Remaining research gaps include: Long-term systemic administration data Optimal dosing strategies outside dermatology Interaction with copper metabolism disorders Comparative efficacy versus standard wound treatments Most evidence supports local, tissue specific effects rather than systemic transformation
Standing Abductions - 3x15-20 ea 5